We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

PolyTherics Announces a Research Collaboration with Spirogen to Develop ADCs

News   Apr 03, 2012

 
PolyTherics Announces a Research Collaboration with Spirogen to Develop ADCs
 
 
 

RELATED ARTICLES

Salty Skin Could Shape Allergy Progression

News

A new cell culture study reveals that salt leads to the formation of Th2 cells - immune cells which are active in allergic conditions such as atopic dermatitis. The team also detected elevated salt concentrations in the skin of patients with atopic dermatitis.

READ MORE

Type 1 Diabetes Could Be Triggered by Viruses That Linger in the Gut

News

Researchers provide new evidence supporting an association between elevated levels of enteroviruses in the intestinal tracts of children and islet autoimmunity, a precursor to Type 1 diabetes.

READ MORE

A Way to Improve Cancer Immunotherapy?

News

A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE